Nuked 
Hey everyone! Buckle up because we’re diving into some exciting developments in health tech that could change everything.
Billy Evans, known for his connection to Elizabeth Holmes of Theranos fame, is back in the game with a new startup aiming to optimize human health through blood testing. This fresh venture, called Haemanthus, claims to have developed a laser-based machine capable of analyzing blood, saliva, and urine samples to spot cancer and infections.
The company plans to kick things off by focusing on pet health before expanding into human diagnostics. They’re seeking to raise over $50 million to bring this innovative idea to life. Interestingly, their approach shares some echoes with Theranos—promising fast, minimal blood draws for a wide range of tests.
Elizabeth Holmes, despite her legal troubles and a prison sentence, remains passionate about making healthcare more accessible. Her latest efforts are viewed with cautious optimism by some investors who have chosen to pass on the project, citing concerns rooted in past controversies.
According to reports from The New York Times, the startup’s marketing materials reveal plans for a machine that uses laser technology to analyze various bodily fluids, potentially detecting illnesses early. The initial focus is on pet health, with hopes to scale up to human testing in the future.
As this story unfolds, it reminds us how the pursuit of innovation in biotech often carries a mix of hope and skepticism. Time will tell if Haemanthus can truly make a health impact or if it will follow the troubled path of past ventures.
